Guy C. Brown
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Guy C. Brown has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Alma Popescu
University of Cambridge, UK
1 shared publicationDavid Allendorf
University of Cambridge, UK
1 shared publication- David Hans Allendorf
Department of Biochemistry University of Cambridge Cambridge UK
1 shared publication - Mar Puigdellívol
Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
1 shared publication
Latest Publications
- Open Access
Activated microglia desialylate their surface, stimulating complement receptor 3‐mediated phagocytosis of neurons
The glycoproteins and glycolipids of the cell surface have sugar chains that normally terminate in a sialic acid residue, but inflammatory activation of myeloid cells can cause sialidase enzymes to remove these residues, resulting in desialylation and altered activity of surface receptors, such as the phagocytic complement receptor 3 (CR3). We found that activation of microglia with lipopolysaccharide (LPS), fibrillar amyloid beta (Aβ), Tau or phorbol myristate acetate resulted in increased surface sialidase activity and desialylation of the microglial surface. Desialylation of microglia by adding sialidase, stimulated microglial phagocytosis of beads, but this was prevented by siRNA knockdown of CD11b or a blocking antibody to CD11b (a component of CR3). Desialylation of microglia by a sialyl‐transferase inhibitor (3FAx‐peracetyl‐Neu5Ac) also stimulated microglial phagocytosis of beads. Desialylation of primary glial‐neuronal co‐cultures by adding sialidase or the sialyl‐transferase inhibitor resulted in neuronal loss that was prevented by inhibiting phagocytosis with cytochalasin D or the blocking antibody to CD11b. Adding desialylated microglia to glial‐neuronal cultures, in the absence of neuronal desialylation, also caused neuronal loss prevented by CD11b blocking antibody. Adding LPS or Aβ to primary glial‐neuronal co‐cultures caused neuronal loss, and this was prevented by inhibiting endogenous sialidase activity with N‐acetyl‐2,3‐dehydro‐2‐deoxyneuraminic acid or blockage of CD11b. Thus, activated microglia release a sialidase activity that desialylates the cell surface, stimulating CR3‐mediated phagocytosis of neurons, making extracellular sialidase and CR3 potential treatment targets to prevent inflammatory loss of neurons.
Open AccessActivated microglia desialylate their surface, stimulating complement receptor 3‐mediated phagocytosis of neurons
The glycoproteins and glycolipids of the cell surface have sugar chains that normally terminate in a sialic acid residue, but inflammatory activation of myeloid cells can cause sialidase enzymes to remove these residues, resulting in desialylation and altered activity of surface receptors, such as the phagocytic complement receptor 3 (CR3). We found that activation of microglia with lipopolysaccharide (LPS), fibrillar amyloid beta (Aβ), Tau or phorbol myristate acetate resulted in increased surface sialidase activity and desialylation of the microglial surface. Desialylation of microglia by adding sialidase, stimulated microglial phagocytosis of beads, but this was prevented by siRNA knockdown of CD11b or a blocking antibody to CD11b (a component of CR3). Desialylation of microglia by a sialyl‐transferase inhibitor (3FAx‐peracetyl‐Neu5Ac) also stimulated microglial phagocytosis of beads. Desialylation of primary glial‐neuronal co‐cultures by adding sialidase or the sialyl‐transferase inhibitor resulted in neuronal loss that was prevented by inhibiting phagocytosis with cytochalasin D or the blocking antibody to CD11b. Adding desialylated microglia to glial‐neuronal cultures, in the absence of neuronal desialylation, also caused neuronal loss prevented by CD11b blocking antibody. Adding LPS or Aβ to primary glial‐neuronal co‐cultures caused neuronal loss, and this was prevented by inhibiting endogenous sialidase activity with N‐acetyl‐2,3‐dehydro‐2‐deoxyneuraminic acid or blockage of CD11b. Thus, activated microglia release a sialidase activity that desialylates the cell surface, stimulating CR3‐mediated phagocytosis of neurons, making extracellular sialidase and CR3 potential treatment targets to prevent inflammatory loss of neurons.
- Open Access
- 1 February 2019
- Published by Portland Press Ltd. in The Biochemist
- Vol. 41 (1) , 32-35
How the brain eats itself
The brain is the basis of the self. We may imagine it to be a relatively unchanging structure, but recent research has shown that the brain is in fact continuously changing its microstructure, and it does so by ‘eating’ itself. The processes of eating things outside the cell, including other cells, is called phagocytosis. In the brain, phagocytosis is performed by a particular type of cell called microglia, which can ‘eat’ neurons (nerve cells) or the connections between neurons (synapses). Microglia engulf neurons and synapses during development in order to sculpt the neural circuits of the brain. Into adulthood, they continue to eat synapses, pathogens and debris in order to shape memory, stop infections and clear accumulating rubbish from the brain. However, too little synaptic pruning by microglia during development may lead to autism; whilst too much eating of synapses during adolescence may contribute to schizophrenia. Too little phagocytosis of debris and protein aggregates or too much eating of synapses and neurons may cause neurodegeneration. A whole host of problems have recently been blamed on excessive phagocytosis in the brain, including aspects of obesity, aging and even sleep deprivation. In this article we will review the evidence, outline what biochemistry can contribute and discuss how to stop the brain eating too much of itself.
- 1 February 2019
- Published by Portland Press Ltd. in The Biochemist
- Vol. 41 (1) , 32-35
Open AccessHow the brain eats itself
The brain is the basis of the self. We may imagine it to be a relatively unchanging structure, but recent research has shown that the brain is in fact continuously changing its microstructure, and it does so by ‘eating’ itself. The processes of eating things outside the cell, including other cells, is called phagocytosis. In the brain, phagocytosis is performed by a particular type of cell called microglia, which can ‘eat’ neurons (nerve cells) or the connections between neurons (synapses). Microglia engulf neurons and synapses during development in order to sculpt the neural circuits of the brain. Into adulthood, they continue to eat synapses, pathogens and debris in order to shape memory, stop infections and clear accumulating rubbish from the brain. However, too little synaptic pruning by microglia during development may lead to autism; whilst too much eating of synapses during adolescence may contribute to schizophrenia. Too little phagocytosis of debris and protein aggregates or too much eating of synapses and neurons may cause neurodegeneration. A whole host of problems have recently been blamed on excessive phagocytosis in the brain, including aspects of obesity, aging and even sleep deprivation. In this article we will review the evidence, outline what biochemistry can contribute and discuss how to stop the brain eating too much of itself.